There was no evidence of a causal relationship between BRCA1/2 pathogenic variants and serous endometrial cancer; carriers of these variants did not have a higher risk of developing the disease, and there were no pathogenic types found in the BRCA1/2 genes in the tumor cells from 15 random cases of serous endometrial cancer. Here, BRCA1 is linked to neoplasm.